MORF has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MORF has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Morphic Holding's selling, general, & admin. expense for the three months ended in Mar. 2024 was $11.16 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2024 was $40.71 Mil.
The historical data trend for Morphic Holding's Selling, General, & Admin. Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Morphic Holding Annual Data | ||||||||||||||||
Trend | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Selling, General, & Admin. Expense | Get a 7-Day Free Trial | 10.23 | 18.50 | 27.81 | 32.14 | 38.82 |
Morphic Holding Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Selling, General, & Admin. Expense | Get a 7-Day Free Trial | 9.28 | 9.58 | 10.38 | 9.58 | 11.16 |
For the Biotechnology subindustry, Morphic Holding's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Morphic Holding's Selling, General, & Admin. Expense distribution charts can be found below:
* The bar in red indicates where Morphic Holding's Selling, General, & Admin. Expense falls into.
Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.
Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $40.71 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Morphic Holding (NAS:MORF) Selling, General, & Admin. Expense Explanation
An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.
Warren Buffett likes companies with consistent SGA as the percentage of gross profit.
Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.
If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.
Thank you for viewing the detailed overview of Morphic Holding's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.
William Devaul | officer: General Counsel and Secretary | C/O MORPHIC HOLDING, INC., 35 GATEHOUSE DRIVE, A2, WALTHAM MA 02451 |
Bruce Rogers | officer: Chief Scientific Officer | C/O MORPHIC HOLDING, INC., 35 GATEHOUSE DRIVE, A2, WALTHAM MA 02451 |
Marc Schegerin | officer: CFO and COO | ARQULE INC, 1 WALL ST FL6, BURLINGTON MA 01803 |
Praveen P. Tipirneni | director, officer: President and CEO | C/O MORPHIC HOLDING, INC.,, 35 GATEHOUSE DRIVE, A2, WALTHAM MA 02451 |
Farrell Robert E Jr | officer: VP Finance and Ops, Secretary | CAMBRIDGE DISCOVERY PARK, 100 ACORN PARK DRIVE, 5TH FLOOR, CAMBRIDGE MA 02140 |
Joseph P Slattery | director | C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560 |
Martin Edwards | director | 15 NEW ENGLAND EXECUTIVE PARK, BURLINGTON MA 01803 |
Timothy A Springer | director, 10 percent owner | 36 WOODMAN ROAD, CHESTNUT HILL MA 02467 |
Peter Linde | officer: Chief Medical Officer | C/O MORPHIC HOLDING, INC., 35 GATEHOUSE DRIVE A2, WALTHAM ME 02451 |
Nisha Nanda | director | 281 TRESSER BOULEVARD, STAMFORD CT 06901 |
Amir Nashat | director | 10835 ROAD TO THE CURE, SUITE 205, SAN DIEGO CA 92121 |
Omega Fund V Gp, L.p. | director | 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199 |
Susannah Gray | director | 10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO CA 92121 |
Vikas Goyal | director | C/O SR ONE, LTD., 161 WASHINGTON ST., SUITE 500, EIGHT TOWER BRIDGE, CONSHOHOCKEN PA 19428 |
Otello Stampacchia | director | 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199 |
From GuruFocus
By GuruFocus Research • 11-03-2023
By Marketwired • 09-22-2023
By GuruFocus Research • 01-18-2024
By Marketwired • 11-03-2023
By Marketwired • 10-24-2023
By Marketwired • 11-02-2023
By GuruFocus Research • 09-09-2023
By GlobeNewswire • 09-22-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.